supplemented nucleofection solution Search Results


90
Lonza supplemented human t cell nucleofection solution
Supplemented Human T Cell Nucleofection Solution, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/supplemented human t cell nucleofection solution/product/Lonza
Average 90 stars, based on 1 article reviews
supplemented human t cell nucleofection solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Amaxa nucleofector solution l-type
Nucleofector Solution L Type, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleofector solution l-type/product/Amaxa
Average 90 stars, based on 1 article reviews
nucleofector solution l-type - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lonza nucleofector solution
Nucleofector Solution, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleofector solution/product/Lonza
Average 90 stars, based on 1 article reviews
nucleofector solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Amaxa supplemented nucleofector solution
Supplemented Nucleofector Solution, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/supplemented nucleofector solution/product/Amaxa
Average 90 stars, based on 1 article reviews
supplemented nucleofector solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lonza p3 primary cell solution
P3 Primary Cell Solution, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p3 primary cell solution/product/Lonza
Average 90 stars, based on 1 article reviews
p3 primary cell solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lonza human stem cell nucleofector kit 1
Human Stem Cell Nucleofector Kit 1, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human stem cell nucleofector kit 1/product/Lonza
Average 90 stars, based on 1 article reviews
human stem cell nucleofector kit 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lonza supplemented human monocyte nucleofector solution
Supplemented Human Monocyte Nucleofector Solution, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/supplemented human monocyte nucleofector solution/product/Lonza
Average 90 stars, based on 1 article reviews
supplemented human monocyte nucleofector solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lonza mouse neural stem cell nucleofector™ kit
Mouse Neural Stem Cell Nucleofector™ Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse neural stem cell nucleofector™ kit/product/Lonza
Average 90 stars, based on 1 article reviews
mouse neural stem cell nucleofector™ kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Amaxa transfection 104 willets
Transfection 104 Willets, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/transfection 104 willets/product/Amaxa
Average 90 stars, based on 1 article reviews
transfection 104 willets - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Amaxa supplemented nucleofector solution l-type
Supplemented Nucleofector Solution L Type, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/supplemented nucleofector solution l-type/product/Amaxa
Average 90 stars, based on 1 article reviews
supplemented nucleofector solution l-type - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

98
Lonza nucleofection solution
Nucleofection Solution, supplied by Lonza, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleofection solution/product/Lonza
Average 98 stars, based on 1 article reviews
nucleofection solution - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

90
Amaxa huvec nucleofector tm solution
Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression in human umbilical vein endothelial cells <t>(HUVECs)</t> in a dose- and time-dependent manner. (A) HUVECs were incubated with S1P for 4 h at the indicated concentrations. RNAs were harvested and analyzed by real-time PCR using specific primer sets for human VEGF-C or GAPDH. (B) HUVECs were incubated with S1P (5 μmol/L) for different time intervals as indicated and subjected to real-time PCR. (C) VEGF-C levels in the supernatant of cultured HUVECs were measured by ELISA after incubation with S1P for 8 h at various concentrations as indicated. (D) HUVECs were incubated with S1P (5 μmol/L) for the indicated time intervals and VEGF-C levels in the supernatant were measured by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.
Huvec Nucleofector Tm Solution, supplied by Amaxa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/huvec nucleofector tm solution/product/Amaxa
Average 90 stars, based on 1 article reviews
huvec nucleofector tm solution - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression in human umbilical vein endothelial cells (HUVECs) in a dose- and time-dependent manner. (A) HUVECs were incubated with S1P for 4 h at the indicated concentrations. RNAs were harvested and analyzed by real-time PCR using specific primer sets for human VEGF-C or GAPDH. (B) HUVECs were incubated with S1P (5 μmol/L) for different time intervals as indicated and subjected to real-time PCR. (C) VEGF-C levels in the supernatant of cultured HUVECs were measured by ELISA after incubation with S1P for 8 h at various concentrations as indicated. (D) HUVECs were incubated with S1P (5 μmol/L) for the indicated time intervals and VEGF-C levels in the supernatant were measured by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.

Journal: Acta Pharmacologica Sinica

Article Title: Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro

doi: 10.1038/aps.2012.186

Figure Lengend Snippet: Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression in human umbilical vein endothelial cells (HUVECs) in a dose- and time-dependent manner. (A) HUVECs were incubated with S1P for 4 h at the indicated concentrations. RNAs were harvested and analyzed by real-time PCR using specific primer sets for human VEGF-C or GAPDH. (B) HUVECs were incubated with S1P (5 μmol/L) for different time intervals as indicated and subjected to real-time PCR. (C) VEGF-C levels in the supernatant of cultured HUVECs were measured by ELISA after incubation with S1P for 8 h at various concentrations as indicated. (D) HUVECs were incubated with S1P (5 μmol/L) for the indicated time intervals and VEGF-C levels in the supernatant were measured by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.

Article Snippet: Cells (5×10 5 ) were resuspended in 100 μL of supplemented HUVEC Nucleofector TM solution (Amaxa Biosystems) and electroporated with 30 pmol siRNA or shRNA.

Techniques: Expressing, Incubation, Real-time Polymerase Chain Reaction, Cell Culture, Enzyme-linked Immunosorbent Assay, Control

Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression by a matrix metalloproteinase (MMP)-2-dependent pathway in human umbilical vein endothelial cells (HUVECs). (A) HUVECs were pretreated with GM6001 (10 μmol/L) for 1 h, followed by S1P (5 μmol/L) treatment for another 4 h. VEGF-C mRNA expression levels were monitored by real-time PCR. (B) siRNA mediated downregulation of MMP-2 mRNA expression in HUVECs. MMP-2 and scrambled siRNA were transfected into HUVECs by electroporation. The transfection efficiency was evaluated by real-time PCR. MMP-2 expression was suppressed in HUVECs transiently transfected with MMP-2 siRNA. (C) HUVECs transfected with scrambled or MMP-2 siRNA were incubated with S1P (5 μmol/L) for 4 h, and VEGF-C mRNA expression levels were monitored by real-time PCR. (D) HUVECs were incubated with S1P (5 μmol/L) for 8 h, and the secreted concentration of VEGF-C protein was determined by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.

Journal: Acta Pharmacologica Sinica

Article Title: Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro

doi: 10.1038/aps.2012.186

Figure Lengend Snippet: Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression by a matrix metalloproteinase (MMP)-2-dependent pathway in human umbilical vein endothelial cells (HUVECs). (A) HUVECs were pretreated with GM6001 (10 μmol/L) for 1 h, followed by S1P (5 μmol/L) treatment for another 4 h. VEGF-C mRNA expression levels were monitored by real-time PCR. (B) siRNA mediated downregulation of MMP-2 mRNA expression in HUVECs. MMP-2 and scrambled siRNA were transfected into HUVECs by electroporation. The transfection efficiency was evaluated by real-time PCR. MMP-2 expression was suppressed in HUVECs transiently transfected with MMP-2 siRNA. (C) HUVECs transfected with scrambled or MMP-2 siRNA were incubated with S1P (5 μmol/L) for 4 h, and VEGF-C mRNA expression levels were monitored by real-time PCR. (D) HUVECs were incubated with S1P (5 μmol/L) for 8 h, and the secreted concentration of VEGF-C protein was determined by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.

Article Snippet: Cells (5×10 5 ) were resuspended in 100 μL of supplemented HUVEC Nucleofector TM solution (Amaxa Biosystems) and electroporated with 30 pmol siRNA or shRNA.

Techniques: Expressing, Real-time Polymerase Chain Reaction, Transfection, Electroporation, Incubation, Concentration Assay, Enzyme-linked Immunosorbent Assay, Control

Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression by a fibroblast growth factor receptor (FGFR)-1-dependent pathway in human umbilical vein endothelial cells (HUVECs). (A) HUVECs were pretreated with SU5402 (5 μmol/L) or AG1478 (100 nmol/L) for 1 h, followed by S1P (5 μmol/L) treatment for another 4 h. VEGF-C mRNA expression levels were monitored by real-time PCR. (B) Total mRNA was extracted from HUVECs, and reverse-transcribed to cDNA. According to real-time PCR, the relative levels of different FGF receptors normalized to GAPDH are shown. (C) FGFR-1 and scrambled siRNA were transfected into HUVECs by electroporation. The transfection efficiency was evaluated by real-time PCR. FGFR-1 expression was suppressed in HUVECs transiently transfected with FGFR-1 siRNA. (D) HUVECs were transfected with scrambled or FGFR-1 siRNA, followed by incubation with S1P (5 μmol/L) for 4 h, and VEGF-C mRNA expression levels were monitored by real-time PCR. (E) HUVECs were incubated with S1P (5 μmol/L) for 8 h, and the secreted concentration of VEGF-C protein was determined by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control. fP<0.01 vs S1P.

Journal: Acta Pharmacologica Sinica

Article Title: Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro

doi: 10.1038/aps.2012.186

Figure Lengend Snippet: Sphingosine-1-phosphate (S1P) upregulates vascular endothelial growth factor (VEGF)-C expression by a fibroblast growth factor receptor (FGFR)-1-dependent pathway in human umbilical vein endothelial cells (HUVECs). (A) HUVECs were pretreated with SU5402 (5 μmol/L) or AG1478 (100 nmol/L) for 1 h, followed by S1P (5 μmol/L) treatment for another 4 h. VEGF-C mRNA expression levels were monitored by real-time PCR. (B) Total mRNA was extracted from HUVECs, and reverse-transcribed to cDNA. According to real-time PCR, the relative levels of different FGF receptors normalized to GAPDH are shown. (C) FGFR-1 and scrambled siRNA were transfected into HUVECs by electroporation. The transfection efficiency was evaluated by real-time PCR. FGFR-1 expression was suppressed in HUVECs transiently transfected with FGFR-1 siRNA. (D) HUVECs were transfected with scrambled or FGFR-1 siRNA, followed by incubation with S1P (5 μmol/L) for 4 h, and VEGF-C mRNA expression levels were monitored by real-time PCR. (E) HUVECs were incubated with S1P (5 μmol/L) for 8 h, and the secreted concentration of VEGF-C protein was determined by ELISA. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control. fP<0.01 vs S1P.

Article Snippet: Cells (5×10 5 ) were resuspended in 100 μL of supplemented HUVEC Nucleofector TM solution (Amaxa Biosystems) and electroporated with 30 pmol siRNA or shRNA.

Techniques: Expressing, Real-time Polymerase Chain Reaction, Reverse Transcription, Transfection, Electroporation, Incubation, Concentration Assay, Enzyme-linked Immunosorbent Assay, Control

Sphingosine-1-phosphate (S1P) induces fibroblast growth factor (FGF) receptor (FGFR)-1 phosphorylation in a time-dependent manner in human umbilical vein endothelial cells (HUVECs). (A) Starved HUVECs were treated with S1P (5 μmol/L) for 1 and 5 min. The concentration of phosphorylated FGFR-1 was measured by an FGFR-1-phospho ELISA kit. (B) HUVECs were pretreated with GM6001 (5 μmol/L) for 1 h, followed by S1P or FGF-2 treatment for 1 min. The concentration of phosphorylated FGFR-1 was measured by an FGFR-1-phospho ELISA kit. All ELISA data are expressed as the mean±SD from at least three independent experiments. bP<0.05 vs control. eP<0.05 vs S1P.

Journal: Acta Pharmacologica Sinica

Article Title: Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro

doi: 10.1038/aps.2012.186

Figure Lengend Snippet: Sphingosine-1-phosphate (S1P) induces fibroblast growth factor (FGF) receptor (FGFR)-1 phosphorylation in a time-dependent manner in human umbilical vein endothelial cells (HUVECs). (A) Starved HUVECs were treated with S1P (5 μmol/L) for 1 and 5 min. The concentration of phosphorylated FGFR-1 was measured by an FGFR-1-phospho ELISA kit. (B) HUVECs were pretreated with GM6001 (5 μmol/L) for 1 h, followed by S1P or FGF-2 treatment for 1 min. The concentration of phosphorylated FGFR-1 was measured by an FGFR-1-phospho ELISA kit. All ELISA data are expressed as the mean±SD from at least three independent experiments. bP<0.05 vs control. eP<0.05 vs S1P.

Article Snippet: Cells (5×10 5 ) were resuspended in 100 μL of supplemented HUVEC Nucleofector TM solution (Amaxa Biosystems) and electroporated with 30 pmol siRNA or shRNA.

Techniques: Phospho-proteomics, Concentration Assay, Enzyme-linked Immunosorbent Assay, Control

Sphingosine-1-phosphate (S1P)-upregulated vascular endothelial growth factor (VEGF)-C mRNA expression is suppressed by shRNA of fibroblast growth factor (FGF)-1 but not siRNA of FGF-2 in human umbilical vein endothelial cells (HUVECs). HUVECs were transfected with scrambled, FGF-1 shRNA (A), and FGF-2 siRNA (B) by electroporation, and the transfection efficiency was evaluated by real-time PCR. FGF-1 (C) and FGF-2 knockdown (D) HUVECs were incubated with S1P (5 μmol/L) for 4 h, and VEGF-C mRNA expression levels were monitored by real-time PCR. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.

Journal: Acta Pharmacologica Sinica

Article Title: Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro

doi: 10.1038/aps.2012.186

Figure Lengend Snippet: Sphingosine-1-phosphate (S1P)-upregulated vascular endothelial growth factor (VEGF)-C mRNA expression is suppressed by shRNA of fibroblast growth factor (FGF)-1 but not siRNA of FGF-2 in human umbilical vein endothelial cells (HUVECs). HUVECs were transfected with scrambled, FGF-1 shRNA (A), and FGF-2 siRNA (B) by electroporation, and the transfection efficiency was evaluated by real-time PCR. FGF-1 (C) and FGF-2 knockdown (D) HUVECs were incubated with S1P (5 μmol/L) for 4 h, and VEGF-C mRNA expression levels were monitored by real-time PCR. Quantified results are shown as the mean±SD from at least three independent experiments. bP<0.05, cP<0.01 vs control.

Article Snippet: Cells (5×10 5 ) were resuspended in 100 μL of supplemented HUVEC Nucleofector TM solution (Amaxa Biosystems) and electroporated with 30 pmol siRNA or shRNA.

Techniques: Expressing, shRNA, Transfection, Electroporation, Real-time Polymerase Chain Reaction, Knockdown, Incubation, Control